Dr. George Siber is an infectious disease trained physician with 40 years’ experience in developing vaccines and antibody products. Dr. George Siber was an Associate Professor of Dana Farber Cancer Institute at Harvard Medical School and Director of the Massachusetts Public Health Biologic Laboratories. Currently he is an Adjunct Professor of Medicine at Johns Hopkins Medical School.Dr. Siber served as Executive Vice President and Chief Scientific Officer of Wyeth Vaccines (Pfizer) 1996-2007, leading the development and approval of multiple childhood vaccines including Prevenar 7 and 13.Currently Dr. Siber is a Co-founder and Board Member of Affinivax and a Board Member of Genocea Biosciences and serves on multiple Scientific Advisory Boards including AdVaccine, Everest, Clover, ILiAD, Valneva, Vaxart and Vaxxinity. Dr. Siber has received multiple awards including the Albert Sabin Gold Medal in vaccinology in 2016.
Prof. Liming Li is the Boya Professor and the Dean of School of Public Health and major Epidemic Prevention and Control, Peking University. The Founder Director General of Chinese Center for Disease Control and Prevention (CDC).Prof. Li has been engaged in the large population cohort study, chronic disease epidemiology, and geriatric epidemiology for a long time. Prof. Li was awarded the EISENHOWER Fellowship Award in 1997; the Johns Hopkins Society of Scholars Award in 2006; Honorary Fellow of the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom (HonFFPH) in 2010 and Academician of International Eurasian Academy of Sciences (IEAS) in 2017.Over 450 publications in peer-reviewed journals
Mr. Luis Barreto has more than 30 years of experience in the fields of public policy, government relations, scientific, medical, clinical development, regulatory affairs and global health. Mr. Barreto obtained his doctor of medicine degree from the University of Nagpur in India in 1979 and master in health sciences from the University of Toronto in 1983.Mr. Barreto joined Sanofi Pasteur and spent over 23 years in R&D, clinical trials and immunization policy advice.Mr. Barreto has served as President of Dr. Luis Barreto & Associates since 2011; since 2016 has served as strategic adviser of NEOMED-LABS Inc. and as senior scientific adviser of Inventprise LLC.
Prof. David Briles is a renowned expert on protein-based Pneumococcal vaccines and a professor of microbiology at the University of Alabama Birmingham (UAB). His research is on the molecular biology and genetics of bacterial pathogenesis, bacterial vaccines, and epidemiology of bacterial infections. His present studies focus on protein virulence factors of pneumococci, their mechanisms of action and potential use in vaccines. Prof. Briles and his team were awarded a number of patents on pneumococcal vaccine antigens.Prof. Briles has served on several study sections at the NIH and FDA and several editorial boards. He has been an advisor about the potential of pneumococcal proteins as human vaccine to the WHO, PAHO, FDA, and the PATH foundation.
Prof. Shan Lu is a physician scientist with research interest in novel vaccine and antibody development, an expert on vaccines for HIV, influenza, biodefense agents, and emerging infectious diseases. Dr. Lu was the past president and a current Executive Board member for the International Society for Vaccines (ISV). Prof. Lu is known as the originator of the DNA prime/protein boost approach to vaccination. He is one of the few people to have developed a candidate vaccine starting at the bench and going all the way to a clinical trial in humans.Prof. Lu is the editor-in-chief of Emerging Microbes & Infections.
Prof. Jingren Zhang is the professor of Medical School in Tsinghua university, mainly focusing on the molecular mechanism of acute pneumonia and related diseases. Dr. Zhang obtained his doctorate in microbiology from the University of Texas Health Science Center-Houston in 1997. During 1998 to 2000, he worked as a postdoctoral fellow in the department of infectious diseases at St. Jude Children’s Research Hospital. Dr. Zhang worked in the China Agricultural University, associate professor from Albany Medical College, US and a visiting professor by institute of microbiology, Chinese Academy of Sciences.